In addition, systemic inflammatory response markers such as C-reactive protein (CRP) have been associated with poor prognosis in patients with many types of cancer [8], including non-small cell lung cancer [9], one of the leading causes of cancer-related deaths worldwide. The gene discussed is CRP; the disease is non-small cell lung carcinoma.